Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Average Recommendation of “Buy” by Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has received an average recommendation of “Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating, one has issued a buy rating and four have given a strong buy rating to the company.

A number of brokerages have recently issued reports on RBGLY. Sanford C. Bernstein cut Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th.

View Our Latest Report on RBGLY

Reckitt Benckiser Group Trading Up 0.8 %

RBGLY stock opened at $12.05 on Wednesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $15.03. The stock’s fifty day simple moving average is $12.25 and its 200-day simple moving average is $11.82.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.